CD70 CAR-T cells is named as a drug or biological intervention in 3 clinical trials in our China trial register, 3 of which are recruiting. Lead sponsors include Chongqing Precision Biotech Co., Ltd (2) and Weijia Fang, MD (1). Registered phase: Phase 1. Conditions studied include Ovarian Cancer; Renal Cell Carcinoma; Cervix Cancer.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05518253 | A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (ClinicalTrials.gov ↗) Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma |
Phase 1 | Recruiting |
| NCT06010875 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (ClinicalTrials.gov ↗) Renal Cell Carcinoma, Ovarian Cancer, Cervix Cancer |
Phase 1 | Recruiting |
| NCT06215950 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer (ClinicalTrials.gov ↗) Ovarian Cancer, Cervix Cancer, Metastatic Cancer |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Ovarian Cancer | 3 |
| Renal Cell Carcinoma | 2 |
| Cervix Cancer | 2 |
| Metastatic Cancer | 2 |
| Advanced Cancer | 1 |
| Metastatic Tumor | 1 |
| Advanced Solid Tumor | 1 |
| Lead sponsor | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 2 |
| Weijia Fang, MD | 1 |
| Register | CD70 CAR-T cells trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how CD70 CAR-T cells works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists CD70 CAR-T cells (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.